ValiRx Share Price | |
---|---|
Price | 3.25 |
Bid | 3.20 |
Ask | 3.30 |
Change | 0.00 (0.00%) |
Volume | 63,583 |
Open | 3.25 |
High | 3.25 |
Low | 3.25 |
Prev. Close | 3.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £4.30m |
Market Size | 30,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.25 |
52 Week Low Date | 02-May-2024 |
# Trades | 9 |
---|---|
Vol. Sold | 39,270 |
Sold Value | £1.26k |
Vol. Bought | 24,313 |
Bought Value | £N/A |
PE Ratio | -1.062092 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:21:45 | 3.201 | 8,692 | Sell* | 3.20 | 3.30 | 278.23 | O Ordinary |
03-May-24 | 16:07:32 | 3.202 | 11,683 | Sell* | 3.20 | 3.30 | 374.09 | O Ordinary |
03-May-24 | 14:31:47 | 3.201 | 1,000 | Sell* | 3.20 | 3.30 | 32.01 | O Ordinary |
03-May-24 | 13:02:08 | 3.202 | 6 | Sell* | 3.20 | 3.30 | 0.19 | O Ordinary |
03-May-24 | 12:41:44 | 3.202 | 5,256 | Sell* | 3.20 | 3.30 | 168.30 | O Ordinary |
03-May-24 | 09:26:00 | 3.28 | 105 | Buy* | 3.20 | 3.30 | 3.44 | O Ordinary |
03-May-24 | 09:20:15 | 3.202 | 3,562 | Sell* | 3.20 | 3.30 | 114.06 | O Ordinary |
03-May-24 | 09:19:36 | 3.202 | 9,071 | Sell* | 3.20 | 3.30 | 290.45 | O Ordinary |
03-May-24 | 08:16:23 | 3.28 | 24,208 | Buy* | 3.20 | 3.30 | 794.02 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 17-Feb-21 | Buy | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 22.25 | GBX | 22,000 | 272,333 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.